These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 29357791)

  • 1. Neurodegenerative Disorders Treatment: The MicroRNA Role.
    Ridolfi B; Abdel-Haq H
    Curr Gene Ther; 2017; 17(5):327-363. PubMed ID: 29357791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNAs and Neurodegenerative Diseases.
    Qiu L; Tan EK; Zeng L
    Adv Exp Med Biol; 2015; 888():85-105. PubMed ID: 26663180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vesicle and CRISPR gene therapy: Current applications in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and Huntington's disease.
    Akyuz E; Aslan FS; Gokce E; Ilmaz O; Topcu F; Kakac S
    Eur J Neurosci; 2024 Oct; 60(8):6057-6090. PubMed ID: 39297377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Updates on the Role of MicroRNA in the Diagnosis and Treatment of Neurodegenerative Diseases.
    Saleem A; Javed M; Akhtar MF; Sharif A; Akhtar B; Naveed M; Saleem U; Baig MMFA; Zubair HM; Bin Emran T; Saleem M; Ashraf GM
    Curr Gene Ther; 2024; 24(2):122-134. PubMed ID: 37861022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Age-Related Neurodegenerative Diseases by AAV-Mediated Gene Therapy.
    Cagin U
    Adv Exp Med Biol; 2021; 1286():213-223. PubMed ID: 33725356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases.
    Nguyen TPN; Kumar M; Fedele E; Bonanno G; Bonifacino T
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNAs as biomarkers of neurodegenerative disorders.
    Viswambharan V; Thanseem I; Vasu MM; Poovathinal SA; Anitha A
    Biomark Med; 2017 Feb; 11(2):151-167. PubMed ID: 28125293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene networks in neurodegenerative disorders.
    Recabarren D; Alarcón M
    Life Sci; 2017 Aug; 183():83-97. PubMed ID: 28623007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay of RNA-Binding Proteins and microRNAs in Neurodegenerative Diseases.
    Kinoshita C; Kubota N; Aoyama K
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene- and cell-based approaches for neurodegenerative disease.
    Urbaniak Hunter K; Yarbrough C; Ciacci J
    Adv Exp Med Biol; 2010; 671():117-30. PubMed ID: 20455500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Delivery for Neurodegenerative Disorders Using Gene Therapy Vectors: Gene Next Therapeutic Goals.
    Singh M; Singh SP; Yadav D; Agarwal M; Agarwal S; Agarwal V; Swargiary G; Srivastava S; Tyagi S; Kaur R; Mani S
    Curr Gene Ther; 2021; 21(1):23-42. PubMed ID: 32811395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
    Duarte FV; Palmeira CM; Rolo AP
    Adv Exp Med Biol; 2015; 888():123-54. PubMed ID: 26663182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulation of exosome function in the CNS: implications for neurodegeneration.
    Properzi F; Ferroni E; Poleggi A; Vinci R
    Swiss Med Wkly; 2015; 145():w14204. PubMed ID: 26561744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer's, Parkinson's, and Huntington's Diseases and Amyotrophic Lateral Sclerosis.
    Ciurea AV; Mohan AG; Covache-Busuioc RA; Costin HP; Glavan LA; Corlatescu AD; Saceleanu VM
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNAi silencing in mouse models of neurodegenerative diseases.
    Farah MH
    Curr Drug Deliv; 2007 Apr; 4(2):161-7. PubMed ID: 17456035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Dysregulated microRNA Biogenesis Machinery and microRNA Sorting on Neurodegenerative Diseases.
    Weng YT; Chang YM; Chern Y
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Status of microRNA-Based Therapeutic Approaches in Neurodegenerative Disorders.
    Paul S; Bravo Vázquez LA; Pérez Uribe S; Roxana Reyes-Pérez P; Sharma A
    Cells; 2020 Jul; 9(7):. PubMed ID: 32679881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA (miRNA) as a biomarker for diagnosis, prognosis, and therapeutics molecules in neurodegenerative disease.
    Alkhazaali-Ali Z; Sahab-Negah S; Boroumand AR; Tavakol-Afshari J
    Biomed Pharmacother; 2024 Aug; 177():116899. PubMed ID: 38889636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapeutic strategies for neurodegenerative diseases.
    Baekelandt V; De Strooper B; Nuttin B; Debyser Z
    Curr Opin Mol Ther; 2000 Oct; 2(5):540-54. PubMed ID: 11249757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal microRNAs as diagnostic biomarkers and therapeutic applications in neurodegenerative diseases.
    Sataer X; Qifeng Z; Yingying Z; Chunhua H; Bingzhenga F; Zhiran X; Wanli L; Yuwei Y; Shuangfeng C; Lingling W; Hongri H; Jibing C; Xiaoping R; Hongjun G
    Neurol Res; 2023 Mar; 45(3):191-199. PubMed ID: 36184105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.